Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer

PurposeThis study was aimed at evaluating whether a radiomics model based on the entire tumor region from breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parametric maps and apparent diffusion coefficient (ADC) maps could indicate the Ki-67 status of patients with breast cancer...

全面介紹

書目詳細資料
發表在:Frontiers in Oncology
Main Authors: Shuqian Feng, Jiandong Yin
格式: Article
語言:英语
出版: Frontiers Media S.A. 2022-11-01
主題:
在線閱讀:https://www.frontiersin.org/articles/10.3389/fonc.2022.847880/full
_version_ 1856924224794394624
author Shuqian Feng
Shuqian Feng
Jiandong Yin
author_facet Shuqian Feng
Shuqian Feng
Jiandong Yin
author_sort Shuqian Feng
collection DOAJ
container_title Frontiers in Oncology
description PurposeThis study was aimed at evaluating whether a radiomics model based on the entire tumor region from breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parametric maps and apparent diffusion coefficient (ADC) maps could indicate the Ki-67 status of patients with breast cancer.Materials and methodsThis retrospective study enrolled 205 women with breast cancer who underwent clinicopathological examination. Among them, 93 (45%) had a low Ki-67 amplification index (Ki-67 positivity< 14%), and 112 (55%) had a high Ki-67 amplification index (Ki-67 positivity ≥ 14%). Radiomics features were extracted from three DCE-MRI parametric maps and ADC maps calculated from two different b values of diffusion-weighted imaging sequences. The patients were randomly divided into a training set (70% of patients) and a validation set (30% of patients). After feature selection, we trained six support vector machine classifiers by combining different parameter maps and used 10-fold cross-validation to predict the expression level of Ki-67. The performance of six classifiers was evaluated with receiver operating characteristic (ROC) analysis, sensitivity, and specificity in both cohorts.ResultsAmong the six classifiers constructed, a radiomics feature set combining three DCE-MRI parametric maps and ADC maps yielded an area under the ROC curve (AUC) of 0.839 (95% confidence interval [CI], 0.768−0.895) within the training set and 0.795 (95% CI, 0.674−0.887) within the independent validation set. Additionally, the AUC value, compared with that for a single parameter map, was moderately increased by combining features from the three parametric maps.ConclusionsRadiomics features derived from the DCE-MRI parametric maps and ADC maps have the potential to serve as imaging biomarkers to determine Ki-67 status in patients with breast cancer.
format Article
id doaj-art-eaf4ef32f6b745a3bd8ea35b472a565a
institution Directory of Open Access Journals
issn 2234-943X
language English
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
spelling doaj-art-eaf4ef32f6b745a3bd8ea35b472a565a2025-08-19T20:16:13ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-11-011210.3389/fonc.2022.847880847880Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancerShuqian Feng0Shuqian Feng1Jiandong Yin2Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, ChinaSchool of Intelligent Medicine, China Medical University, Shenyang, Liaoning, ChinaDepartment of Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, ChinaPurposeThis study was aimed at evaluating whether a radiomics model based on the entire tumor region from breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parametric maps and apparent diffusion coefficient (ADC) maps could indicate the Ki-67 status of patients with breast cancer.Materials and methodsThis retrospective study enrolled 205 women with breast cancer who underwent clinicopathological examination. Among them, 93 (45%) had a low Ki-67 amplification index (Ki-67 positivity< 14%), and 112 (55%) had a high Ki-67 amplification index (Ki-67 positivity ≥ 14%). Radiomics features were extracted from three DCE-MRI parametric maps and ADC maps calculated from two different b values of diffusion-weighted imaging sequences. The patients were randomly divided into a training set (70% of patients) and a validation set (30% of patients). After feature selection, we trained six support vector machine classifiers by combining different parameter maps and used 10-fold cross-validation to predict the expression level of Ki-67. The performance of six classifiers was evaluated with receiver operating characteristic (ROC) analysis, sensitivity, and specificity in both cohorts.ResultsAmong the six classifiers constructed, a radiomics feature set combining three DCE-MRI parametric maps and ADC maps yielded an area under the ROC curve (AUC) of 0.839 (95% confidence interval [CI], 0.768−0.895) within the training set and 0.795 (95% CI, 0.674−0.887) within the independent validation set. Additionally, the AUC value, compared with that for a single parameter map, was moderately increased by combining features from the three parametric maps.ConclusionsRadiomics features derived from the DCE-MRI parametric maps and ADC maps have the potential to serve as imaging biomarkers to determine Ki-67 status in patients with breast cancer.https://www.frontiersin.org/articles/10.3389/fonc.2022.847880/fullbreast cancerradiomicsdynamic contrast-enhanced magnetic resonance imagingapparent diffusion coefficientKi-67
spellingShingle Shuqian Feng
Shuqian Feng
Jiandong Yin
Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer
breast cancer
radiomics
dynamic contrast-enhanced magnetic resonance imaging
apparent diffusion coefficient
Ki-67
title Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer
title_full Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer
title_fullStr Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer
title_full_unstemmed Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer
title_short Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer
title_sort radiomics of dynamic contrast enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict ki 67 status in breast cancer
topic breast cancer
radiomics
dynamic contrast-enhanced magnetic resonance imaging
apparent diffusion coefficient
Ki-67
url https://www.frontiersin.org/articles/10.3389/fonc.2022.847880/full
work_keys_str_mv AT shuqianfeng radiomicsofdynamiccontrastenhancedmagneticresonanceimagingparametricmapsandapparentdiffusioncoefficientmapstopredictki67statusinbreastcancer
AT shuqianfeng radiomicsofdynamiccontrastenhancedmagneticresonanceimagingparametricmapsandapparentdiffusioncoefficientmapstopredictki67statusinbreastcancer
AT jiandongyin radiomicsofdynamiccontrastenhancedmagneticresonanceimagingparametricmapsandapparentdiffusioncoefficientmapstopredictki67statusinbreastcancer